Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Panel Back On Track For TransMedics’ Heart Device After Missing A Few Beats

Executive Summary

The US FDA will host an advisory committee webcast to discuss approval of the company’s new heart transplant device a year after it was originally planned.

You may also be interested in...



TransMedics Faces 2nd Panel Date Postponement

The company said the postponement will give the US FDA additional time to review trial data.

FDA May Webcast First MDUFA Meeting, Postpone Or Cancel Others

The FDA says it is looking to webcast the upcoming 7 April MDUFA user fee public meeting, which is slated to be one of the most important agency meetings of the year. The decision comes in light of difficulties holding in-person meetings as the US grapples with the ongoing coronavirus crisis.

Digital Health Roundup, March 2021: Record-Breaking Funding; Exec Chats With Medtronic, Edwards LifeSciences

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news to date.

Topics

UsernamePublicRestriction

Register

MT143582

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel